Hello and welcome to the details of Johnson & Johnson Covid-19 vaccine shipping to US, but new deliveries hinge on regulators and now with the details
Subscribe to our Telegram channel for the latest updates on news you need to know.
NEW YORK, March 2 ― Johnson & Johnson will ship nearly 4 million doses of its newly authorised single-dose Covid-19 vaccine around the United States this week, but a top executive said yesterday that the next round of deliveries is contingent on regulatory approvals at a new plant.
The drugmaker expects to deliver another 16 million doses of the vaccine by the end of this month. But none is expected to go out next week.
“Four million doses are already on trucks to different places in the US,” J&J Chief Scientific Officer Paul Stoffels said in an interview, noting that those doses came from a smaller plant already up and running.
He said a new, larger plant operated by contract manufacturer Catalent Inc has been preparing doses, but the US Food and Drug Administration (FDA) still needs to allow the companies to begin shipping them.
“The FDA is looking at all the quality data and, hopefully, very quickly we'll be able to get approval to ship from that plant and then we get going.”
Stoffels said he expects the Catalent plant to receive approval in the next few days and the company would be able to meet its promise to supply 20 million doses of the vaccine by the end of March.
Catalent said it may take a bit longer.
“Catalent is on track to deliver on our commitments for Johnson & Johnson Covid-19 vaccine deliveries as soon as we are approved to begin shipments by the FDA, which we anticipate in the coming weeks,” Mike Riley, president for Catalent North America, said in a statement.
Shots in arms
J&J Chief Executive Office Alex Gorsky said in an interview with NBC News' Today programme that Americans should begin getting his company's shot today or tomorrow.
“Within the next 24 to 28 hours, Americans should start receiving shots in arms,” he told NBC News.
The coronavirus has been circulating for more than a year, and in recent months new virus variants have arisen against which the J&J vaccine and others appear less effective. Public health officials say a global vaccination effort can help stem these variants from developing.
Gorsky said J&J was confident that its vaccine would have a “robust response” against these emerging variants, based on its clinical trials in countries including South Africa and Brazil where worrisome variants were circulating.
The company is developing a version of its vaccine to target the variant first found in South Africa, and will be ready to start late-stage trials by this summer.
Pfizer and German partner BioNTech and Moderna Inc have FDA-authorised two-dose vaccines.
Shares of J&J closed up 0.6 per cent at US$159.39 (RM646.58) . The FDA gave it emergency use authorisation on Saturday.
McKesson Corp said yesterday it had begun distributing the vaccine. ― Reuters
These were the details of the news Johnson & Johnson Covid-19 vaccine shipping to US, but new deliveries hinge on regulators for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.
It is also worth noting that the original news has been published and is available at Malay Mail and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.